AI in pediatric care: questions for families and teams
By ChatGPT Health. Educational synthesis prepared with AI assistance. Sources checked September 28, 2026. Clinically reviewed by Harvey Castro, MD, MBA, on September 28, 2026. Approved as educational content. This page is not a clinical protocol.
Children need evidence that matches their age, developmental stage and care setting. An adult validation study alone cannot establish how a tool performs in pediatric care.
Start with the age range
Ask which ages were included in development and testing, how many children were studied, and whether performance differs across age groups. Record the exact task and version. A tool that summarizes a visit needs different evidence and safeguards from one that influences a diagnosis or medication decision.
A specific pediatric example
The ACCESS trial studied 164 young people aged 8 to 21 with diabetes at one academic center. Eye examination completion within six months was 100% with an AI exam at the diabetes visit versus 22% with referral and education. This supports improved screening access in that pathway; it does not establish better vision outcomes or validate unrelated pediatric AI uses. Read ACCESS.
Questions for parents and caregivers
- What will this tool change about the visit, and who checks its result?
- Can the child and family understand the explanation and ask for human review?
- What information is collected, who can see it and how is the child’s privacy protected?
- What happens if the test cannot produce a result or disagrees with the clinical assessment?
- Is the next step available, affordable and clear to the family?
What clinical teams should examine
Include appropriate pediatric expertise in the evaluation. Test missing data, age and unit errors, communication needs and the transition from screening to follow up. Record consent and assent processes appropriate to the service. Examine performance across the groups the tool will serve, including language and disability differences.
Research and authorization are separate
A trial report does not by itself establish a product’s authorized age range or intended use. Check the current device documentation and the relevant jurisdiction before clinical deployment. FDA information on AI enabled devices. Families should take symptoms and treatment questions to their child’s care team rather than using a general chatbot to rule out illness.
Sources
Explore related topics
Put the evidence to work
Download the evidence and safety evaluation worksheets or compare the study designs and their limits.
Editorial standards · Suggest a correction. Please do not send identifiable patient information.